Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers

Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers

Bibliographic Details
Main Authors:	Golan, T, Kanji, Z S, Epelbaum, R, Devaud, N, Dagan, E, Holter, S, Aderka, D, Paluch-Shimon, S, Kaufman, B, Gershoni-Baruch, R, Hedley, D, Moore, M J, Friedman, E, Gallinger, S
Format:	Online
Language:	English
Published:	Nature Publishing Group 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453851/

Similar Items

BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts
by: Lohse, I, et al.
Published: (2015)

Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers
by: Friedman, Eitan, et al.
Published: (2006)

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
by: Iqbal, J, et al.
Published: (2012)

Management of the asymptomatic BRCA mutation carrier
by: Teller, Paige, et al.
Published: (2010)

Selenium and the risk of cancer in BRCA1 carriers
by: Lubinski, J, et al.
Published: (2011)

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
by: Metcalfe, K, et al.
Published: (2011)

Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
by: Kotsopoulos, Joanne, et al.
Published: (2012)

POTENTIAL CONSEQUENCES OF THE BRCA1 MUTATION CARRIER STATE ON ESTROGEN RESPONSIVE ORGANS
by: Yen, Hai-Yun, et al.
Published: (2012)

Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers: A Review
by: Bougie, O., et al.
Published: (2011)

Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment
by: Byrski, T, et al.
Published: (2012)

Folic acid and cancer risk in BRCA1 carriers
by: Durda, Katarzyna, et al.
Published: (2012)

Cisplatin in breast cancer treatment in BRCA1 carriers
by: Gronwald, Jacek, et al.
Published: (2012)

A review of BRCA gene carrier demographics in Wales
by: Evans, Tom, et al.
Published: (2015)

Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers
by: Antoniou, Antonis C, et al.
Published: (2006)

RANKL/OPG in Breast Cancer — Extending Its Territory to BRCA Mutation Carriers
by: Rachner, Tilman D., et al.
Published: (2015)

Management of Breast Cancer in BRCA1/2 Mutation Carriers
by: Eeles, R. A., et al.
Published: (1999)

HIF-1α Overexpression in Ductal Carcinoma In Situ of the Breast in BRCA1 and BRCA2 Mutation Carriers
by: van der Groep, Petra, et al.
Published: (2013)

Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific
by: Chehade, Rania, et al.
Published: (2016)

Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy
by: Schmidt, MK, et al.
Published: (2005)

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
by: Zaaijer, Leendert H, et al.
Published: (2016)

Vitamins A, E and D and cancer risk in BRCA1 carriers
by: Kąklewski, K, et al.
Published: (2012)

DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
by: Osorio, Ana, et al.
Published: (2014)

Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis
by: Metcalfe, Kelly, et al.
Published: (2014)

DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3
by: Yang, Rachel L., et al.
Published: (2015)

BRCA2 mutation carriers, reproductive factors and breast cancer risk
by: Tryggvadottir, Laufey, et al.
Published: (2003)

Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
by: Kotsopoulos, Joanne, et al.
Published: (2005)

Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
by: Phillips, KA, et al.
Published: (2012)

Classifications within Molecular Subtypes Enables Identification of BRCA1/BRCA2 Mutation Carriers by RNA Tumor Profiling
by: Larsen, Martin J., et al.
Published: (2013)

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
by: Kuchenbaecker, Karoline B, et al.
Published: (2014)

Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study
by: Phelan, C M, et al.
Published: (2014)

The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers
by: Spurdle, Amanda B, et al.
Published: (2005)

Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis
by: Phi, Xuan-Anh, et al.
Published: (2016)

Effects of Combined Treatment with Ionizing Radiation and the PARP Inhibitor Olaparib in BRCA Mutant and Wild Type Patient-Derived Pancreatic Cancer Xenografts
by: Lohse, Ines, et al.
Published: (2016)

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
by: Silvestri, Valentina, et al.
Published: (2016)

Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers
by: Maia, Ana-Teresa, et al.
Published: (2012)

An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)
by: Chenevix-Trench, Georgia, et al.
Published: (2007)

Future possibilities in the prevention of breast cancer: Intervention strategies in BRCA1 and BRCA2 mutation carriers
by: Eeles, Rosalind A
Published: (2000)

Exploring the acceptability of, and preferences for, an ongoing support network for known BRCA1 and BRCA2 mutation carriers
by: Hughes, L, et al.
Published: (2008)

Other cancers in BRCA1 and BRCA2 mutation carriers: implications for counselling and follow up
by: Ponder, B
Published: (2000)

A prospective investigation of predictive and modifiable risk factors for breast cancer in unaffected BRCA1 and BRCA2 gene carriers
by: Guinan, Emer M, et al.
Published: (2013)